PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation

Background. Natalizumab treatment is frequently discontinued and replaced by alternative medication in multiple sclerosis (MS) patients having a high risk of progressive multifocal leukoencephalopathy (PML). Case Presentation. We report a PML case that was missed on magnetic resonance imaging (MRI)...

Descripción completa

Detalles Bibliográficos
Autores principales: Killestein, J., Vennegoor, A., van Golde, A. E. L., Bourez, R. L. J. H., Wijlens, M. L. B., Wattjes, M. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258922/
https://www.ncbi.nlm.nih.gov/pubmed/25506447
http://dx.doi.org/10.1155/2014/307872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258922/
https://www.ncbi.nlm.nih.gov/pubmed/25506447
http://dx.doi.org/10.1155/2014/307872

Ejemplares similares